1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Patologia i Terapèutica Experimental
  4. Articles publicats en revistes (Patologia i Terapèutica Experimental)
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/190602
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBonaventura, Jordi-
dc.contributor.authorEldridge, Mark A.G.-
dc.contributor.authorHu, Feng-
dc.contributor.authorGomez, Juan L.-
dc.contributor.authorSánchez Soto, Marta-
dc.contributor.authorAbramyan, Ara M.-
dc.contributor.authorLam, Sherry-
dc.contributor.authorBoehm, Matthew A.-
dc.contributor.authorRuiz, Christina-
dc.contributor.authorFarrell, Mitchell R.-
dc.contributor.authorMoreno, Andrea-
dc.contributor.authorGalal Faress, Islam Mustafa-
dc.contributor.authorAndersen, Niels-
dc.contributor.authorLinm John Y.-
dc.contributor.authorMoaddel, Ruin-
dc.contributor.authorMorris, Patrick J.-
dc.contributor.authorShi, Lei-
dc.contributor.authorSibley, David R.-
dc.contributor.authorMahler, Stephen V.-
dc.contributor.authorNabavi, Sadegh-
dc.contributor.authorPomper, Martin G.-
dc.contributor.authorBonci, Antonello-
dc.contributor.authorHorti, Andrew G.-
dc.contributor.authorRichmond, Barry J.-
dc.contributor.authorMichaelides, Michael-
dc.date.accessioned2022-11-08T18:56:24Z-
dc.date.available2022-11-08T18:56:24Z-
dc.date.issued2019-10-11-
dc.identifier.issn2041-1723-
dc.identifier.urihttps://hdl.handle.net/2445/190602-
dc.description.abstractDesigner Receptors Exclusively Activated by Designer Drugs (DREADDs) are a popular chemogenetic technology for manipulation of neuronal activity in uninstrumented awake animals with potential for human applications as well. The prototypical DREADD agonist clozapine N-oxide (CNO) lacks brain entry and converts to clozapine, making it difficult to apply in basic and translational applications. Here we report the development of two novel DREADD agonists, JHU37152 and JHU37160, and the first dedicated 18F positron emission tomography (PET) DREADD radiotracer, [18F]JHU37107. We show that JHU37152 and JHU37160 exhibit high in vivo DREADD potency. [18F]JHU37107 combined with PET allows for DREADD detection in locally-targeted neurons, and at their long-range projections, enabling noninvasive and longitudinal neuronal projection mapping.-
dc.format.extent12 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41467-019-12236-z-
dc.relation.ispartofNature Communications, 2019, vol. 10-
dc.relation.urihttps://doi.org/10.1038/s41467-019-12236-z-
dc.rightscc-by (c) Bonaventura, Jordi et al., 2019-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationAnimals-
dc.subject.classificationAntipsicòtics-
dc.subject.classificationCervell-
dc.subject.classificationDrogues de disseny-
dc.subject.otherAnimals-
dc.subject.otherAntipsychotic drugs-
dc.subject.otherBrain-
dc.subject.otherDesigner drugs-
dc.titleHigh-potency ligands for DREADD imaging and activation in rodents and monkeys-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec712840-
dc.date.updated2022-11-08T18:56:24Z-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/679714/EU//STC-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
712840.pdf2.14 MBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons